HDAC9 and cancer: Drugs targeting epigenetic writers and erasers for cancer therapy first started with the concept of inhibiting individual targets with drugs such as HDAC inhibitors (HDACis), histone methyltransferase inhibitors, and DNA methyltransferase inhibitors.